BioProcess International, Europe
BioProcess International (BPI) Europe 2026 focuses on the transition from innovation to implementation in biopharmaceutical manufacturing. The event brings together scientists and industry stakeholders working across monoclonal antibodies, biologics, and Advanced Therapy Medicinal Products (ATMPs).
The conference takes place in Vienna, a leading European life science hub, home to institutions such as the Vienna BioCenter and major industry players including Boehringer Ingelheim, Takeda, and Novartis. This setting supports engagement across academia and industry within a well-established innovation ecosystem.
The program addresses the full bioprocessing lifecycle, with a focus on translating scientific advances into scalable manufacturing solutions. Key topics include digital tools, facility design, and strategies to accelerate development timelines while maintaining quality and compliance.
As bioprocessing evolves, the agenda reflects key industry drivers such as adaptability, speed, and scalability. Discussions center on how manufacturers can respond to increasing modality complexity, smaller batch sizes, and growing global demand while ensuring long-term resilience.
